Significance of gut breast cancer resistance protein versus organic anion transporting polypeptide 2B1 inhibition on rosuvastatin clinical drug-drug interactions.
Saved in:
| Title: | Significance of gut breast cancer resistance protein versus organic anion transporting polypeptide 2B1 inhibition on rosuvastatin clinical drug-drug interactions. |
|---|---|
| Authors: | West MA; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Research and Development, Pfizer Inc., Groton, Connecticut., Lazzaro S; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Research and Development, Pfizer Inc., Groton, Connecticut., Morrow R; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Research and Development, Pfizer Inc., Groton, Connecticut., Costales C; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Research and Development, Pfizer Inc., Groton, Connecticut., Yee SW; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Research and Development, Pfizer Inc., Groton, Connecticut., Varma MVS; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Research and Development, Pfizer Inc., Groton, Connecticut. Electronic address: manthena.v.varma@pfizer.com. |
| Source: | Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2025 Apr; Vol. 53 (4), pp. 100056. Date of Electronic Publication: 2025 Mar 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society for Pharmacology and Experimental Therapeutics, etc.] Country of Publication: Netherlands NLM ID: 9421550 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-009X (Electronic) Linking ISSN: 00909556 NLM ISO Abbreviation: Drug Metab Dispos Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40220705 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Significance of gut breast cancer resistance protein versus organic anion transporting polypeptide 2B1 inhibition on rosuvastatin clinical drug-drug interactions. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22West+MA%22">West MA</searchLink>; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Research and Development, Pfizer Inc., Groton, Connecticut.<br /><searchLink fieldCode="AU" term="%22Lazzaro+S%22">Lazzaro S</searchLink>; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Research and Development, Pfizer Inc., Groton, Connecticut.<br /><searchLink fieldCode="AU" term="%22Morrow+R%22">Morrow R</searchLink>; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Research and Development, Pfizer Inc., Groton, Connecticut.<br /><searchLink fieldCode="AU" term="%22Costales+C%22">Costales C</searchLink>; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Research and Development, Pfizer Inc., Groton, Connecticut.<br /><searchLink fieldCode="AU" term="%22Yee+SW%22">Yee SW</searchLink>; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Research and Development, Pfizer Inc., Groton, Connecticut.<br /><searchLink fieldCode="AU" term="%22Varma+MVS%22">Varma MVS</searchLink>; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Research and Development, Pfizer Inc., Groton, Connecticut. Electronic address: manthena.v.varma@pfizer.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229421550%22">Drug metabolism and disposition: the biological fate of chemicals</searchLink> [Drug Metab Dispos] 2025 Apr; Vol. 53 (4), pp. 100056. <i>Date of Electronic Publication: </i>2025 Mar 04. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Pharmacology+and+Experimental+Therapeutics%2C+etc%2E]%22">American Society for Pharmacology and Experimental Therapeutics, etc.] </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>9421550 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1521-009X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200909556%22">00909556 </searchLink><i>NLM ISO Abbreviation: </i>Drug Metab Dispos <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40220705 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.dmd.2025.100056 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 100056 Titles: – TitleFull: Significance of gut breast cancer resistance protein versus organic anion transporting polypeptide 2B1 inhibition on rosuvastatin clinical drug-drug interactions. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: West MA – PersonEntity: Name: NameFull: Lazzaro S – PersonEntity: Name: NameFull: Morrow R – PersonEntity: Name: NameFull: Costales C – PersonEntity: Name: NameFull: Yee SW – PersonEntity: Name: NameFull: Varma MVS IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2025 Apr Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1521-009X Numbering: – Type: volume Value: 53 – Type: issue Value: 4 Titles: – TitleFull: Drug metabolism and disposition: the biological fate of chemicals Type: main |
| ResultId | 1 |
